Matthew Gline is CEO of Roivant Sciences Ltd.. Currently has a direct ownership of 17.4 Million shares of ROIV, which is worth approximately $201 Million. The most recent transaction as insider was on Nov 20, 2024, when has been sold 10,945 shares (Common Shares) at a price of $11.49 per share, resulting in proceeds of $125,758. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.4M
5.21% 3M change
1623.83% 12M change
Total Value Held $201 Million

Matthew Gline Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 20 2024
SELL
Payment of exercise price or tax liability
$125,758 $11.49 p/Share
10,945 Reduced 0.06%
17,350,114 Common Shares
Oct 20 2024
SELL
Payment of exercise price or tax liability
$130,464 $11.92 p/Share
10,945 Reduced 0.06%
17,361,059 Common Shares
Sep 23 2024
SELL
Other acquisition or disposition
$5,967,511 $11.97 p/Share
498,539 Reduced 2.79%
17,372,004 Common Shares
Sep 23 2024
SELL
Open market or private sale
$23,382,600 $11.79 p/Share
1,983,257 Reduced 9.99%
17,870,543 Common Shares
Sep 23 2024
BUY
Exercise of conversion of derivative security
$5,967,500 $3.85 p/Share
1,550,000 Added 7.24%
19,853,800 Common Shares
Sep 20 2024
SELL
Payment of exercise price or tax liability
$131,011 $11.97 p/Share
10,945 Reduced 0.06%
18,303,800 Common Shares
Aug 20 2024
SELL
Payment of exercise price or tax liability
$125,671 $11.48 p/Share
10,947 Reduced 0.06%
18,314,745 Common Shares
Jul 26 2024
BUY
Grant, award, or other acquisition
-
17,204,821 Added 48.42%
18,325,692 Common Shares
Jul 20 2024
SELL
Payment of exercise price or tax liability
$120,395 $11.0 p/Share
10,945 Reduced 0.97%
1,120,871 Common Shares
Jun 20 2024
SELL
Payment of exercise price or tax liability
$118,206 $10.8 p/Share
10,945 Reduced 0.96%
1,131,816 Common Shares
May 20 2024
SELL
Payment of exercise price or tax liability
$124,444 $11.37 p/Share
10,945 Reduced 0.95%
1,142,761 Common Shares
Apr 20 2024
SELL
Payment of exercise price or tax liability
$114,484 $10.46 p/Share
10,945 Reduced 0.94%
1,153,706 Common Shares
Mar 30 2024
SELL
Payment of exercise price or tax liability
$2,276,545 $10.54 p/Share
215,991 Reduced 15.64%
1,164,651 Common Shares
Mar 30 2024
BUY
Exercise of conversion of derivative security
-
390,579 Added 22.05%
1,380,642 Common Shares
Mar 20 2024
SELL
Payment of exercise price or tax liability
$109,559 $10.01 p/Share
10,945 Reduced 1.09%
990,063 Common Shares
Feb 20 2024
SELL
Payment of exercise price or tax liability
$126,305 $11.54 p/Share
10,945 Reduced 1.08%
1,001,008 Common Shares
Jan 20 2024
SELL
Payment of exercise price or tax liability
$113,280 $10.35 p/Share
10,945 Reduced 1.07%
1,011,953 Common Shares
Dec 27 2023
SELL
Payment of exercise price or tax liability
$255,257 $11.58 p/Share
22,043 Reduced 2.11%
1,022,898 Common Shares
Dec 27 2023
BUY
Exercise of conversion of derivative security
-
38,453 Added 3.55%
1,044,941 Common Shares
Dec 20 2023
SELL
Payment of exercise price or tax liability
$109,012 $9.96 p/Share
10,945 Reduced 1.08%
1,006,488 Common Shares
Nov 22 2023
SELL
Other acquisition or disposition
$98,240 $8.68 p/Share
11,318 Reduced 1.1%
1,017,433 Common Shares
Oct 24 2023
SELL
Other acquisition or disposition
$112,276 $8.99 p/Share
12,489 Reduced 1.2%
1,028,751 Common Shares
Sep 28 2023
SELL
Other acquisition or disposition
$129,778 $12.67 p/Share
10,243 Reduced 0.97%
1,041,240 Common Shares
Sep 27 2023
BUY
Exercise of conversion of derivative security
-
17,762 Added 1.66%
1,051,483 Common Shares
Sep 22 2023
SELL
Other acquisition or disposition
$114,403 $10.19 p/Share
11,227 Reduced 1.07%
1,033,721 Common Shares
MG

Matthew Gline

CEO
London, X0

Track Institutional and Insider Activities on ROIV

Follow Roivant Sciences Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ROIV shares.

Notify only if

Insider Trading

Get notified when an Roivant Sciences Ltd. insider buys or sells ROIV shares.

Notify only if

News

Receive news related to Roivant Sciences Ltd.

Track Activities on ROIV